These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 25733811

  • 1. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
    Venugopala KN, Govender R, Khedr MA, Venugopala R, Aldhubiab BE, Harsha S, Odhav B.
    Drug Des Devel Ther; 2015; 9():911-21. PubMed ID: 25733811
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents.
    Rahmouni A, Souiei S, Belkacem MA, Romdhane A, Bouajila J, Ben Jannet H.
    Bioorg Chem; 2016 Jun; 66():160-8. PubMed ID: 27179178
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
    Filali I, Belkacem MA, Ben Nejma A, Souchard JP, Ben Jannet H, Bouajila J.
    J Enzyme Inhib Med Chem; 2016 Jun; 31(sup1):23-33. PubMed ID: 27028352
    [Abstract] [Full Text] [Related]

  • 4. Novel heterocyclic-fused pyrimidine derivatives: synthesis, molecular modeling and pharmacological screening.
    Arafa RK, Nour MS, El-Sayed NA.
    Eur J Med Chem; 2013 Nov; 69():498-507. PubMed ID: 24090920
    [Abstract] [Full Text] [Related]

  • 5. Design, Synthesis and Biological Evaluation of Some 5-Arylthieno[2,3-d]pyrimidines as Potential Anti-cancer Agents.
    El-Ansary AK, Kamal AM, Al-Ghorafi MA.
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(8):1172-80. PubMed ID: 27477657
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
    Filali I, Bouajila J, Znati M, Bousejra-El Garah F, Ben Jannet H.
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
    Barakat A, Islam MS, Al-Majid AM, Ghabbour HA, Fun HK, Javed K, Imad R, Yousuf S, Choudhary MI, Wadood A.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6740-8. PubMed ID: 26381063
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives.
    Cai J, Zhang S, Zheng M, Wu X, Chen J, Ji M.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):806-10. PubMed ID: 22217877
    [Abstract] [Full Text] [Related]

  • 9. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
    Banti CN, Kyros L, Geromichalos GD, Kourkoumelis N, Kubicki M, Hadjikakou SK.
    Eur J Med Chem; 2014 Apr 22; 77():388-99. PubMed ID: 24681027
    [Abstract] [Full Text] [Related]

  • 10. Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors.
    Zhang JQ, Luo YJ, Xiong YS, Yu Y, Tu ZC, Long ZJ, Lai XJ, Chen HX, Luo Y, Weng J, Lu G.
    J Med Chem; 2016 Aug 11; 59(15):7268-74. PubMed ID: 27427973
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY, Pang LP, Wang B, Zhang M, Hu B, Xue DQ, Shao KP, Zhang BL, Liu Y, Zhang E, Liu HM.
    Eur J Med Chem; 2014 Oct 30; 86():368-80. PubMed ID: 25180925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
    Shi HB, Li HB, Lu KQ, Zhu XR, Hu WX, Pei W.
    Arch Pharm (Weinheim); 2011 Oct 30; 344(10):675-83. PubMed ID: 21984017
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis of Hybrids of Dihydropyrimidine and Pyridazinone as potential Anti-Breast Cancer Agents.
    Akhtar W, Verma G, Khan MF, Shaquiquzzaman M, Rana A, Anwer T, Akhter M, Alam MM.
    Mini Rev Med Chem; 2018 Oct 30; 18(4):369-379. PubMed ID: 28486908
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors.
    El-Hamamsy MH, Sharafeldin NA, El-Moselhy TF, Tawfik HO.
    Arch Pharm (Weinheim); 2020 Aug 30; 353(8):e2000060. PubMed ID: 32452567
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
    Kassab AE, Gedawy EM.
    Eur J Med Chem; 2013 May 30; 63():224-30. PubMed ID: 23501108
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies.
    Shahid W, Ashraf M, Saleem M, Bashir B, Muzaffar S, Ali M, Kaleem A, Aziz-Ur-Rehman, Amjad H, Bhattarai K, Riaz N.
    Bioorg Chem; 2021 Oct 30; 115():105261. PubMed ID: 34416506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.